Differential regulation of STING expression and cisplatin sensitivity by autophagy in non-small cell lung cancer

Sevim Aydemir1, Zafer Yildirim1, Busra Bara1

  • 1Faculty of Medicine, Department of Medical Biology, Ege University, Izmir, Türkiye.

Insights

The cGAS-STING pathway

Area of Science:

  • Cellular Biology
  • Immunology
  • Oncology

Background:

  • The cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) pathway is crucial for inflammatory responses and is activated by cisplatin.
  • Increased autophagy correlates with cisplatin resistance in non-small cell lung cancer (NSCLC), but the interplay between autophagy and STING in this context is unknown.

Purpose of the Study:

  • To investigate how modulating autophagy impacts STING expression and cisplatin sensitivity in NSCLC cells with varying basal STING levels.

Main Methods:

  • Autophagy was manipulated using chloroquine (inhibition) and serum starvation (induction) in Calu-1 and H2030 NSCLC cell lines.
  • STING expression, cGAS-STING pathway activation, interferon responses, and cisplatin sensitivity were assessed.

Main Results:

  • In Calu-1 cells (high basal STING), cisplatin increased STING, activated cGAS-STING, and induced interferon responses.
  • Autophagy inhibition enhanced cisplatin sensitivity by reducing STING and interferon activation.
  • Autophagy induction decreased cisplatin sensitivity, with serum starvation selectively increasing ISG15 expression.
  • H2030 cells (low basal STING) showed minimal responses to cisplatin or autophagy modulation.

Conclusions:

  • STING expression levels are critical determinants of autophagy-mediated responses to DNA-damaging chemotherapy in NSCLC.
  • Targeting the autophagy-STING axis may offer therapeutic strategies for NSCLC.

Related Concept Videos

Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.6K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.9K